CodeMap® 

150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2021
2020 (July)

Physician Fee Schedule

2021
2020

OPPS Fee Schedule

2021-April
2021-January

ASC Fee Schedule

2021-April
2021-January

APC Codes

2021-April
2021-January

DRG Codes

2021
2020

ASP Drug Pricing Files

April 2021
January 2021


CMS Transmittals




Next Webinar 06/23/2021:
2021 Regulatory Update: Hospital Outreach Programs

CodeMap® COVID-19 Testing: Present and Upcoming Coding, Reimbursement, and Compliance Issues::Recorded April 21, 2021

COVID-19 Testing:
Present and Upcoming Coding, Reimbursement, and Compliance Issues

Wednesday, April 21, 2021
2:00 - 3:15 pm ET

As a nation, we have endured the COVID-19 pandemic for well over a year. From the beginning, both international and domestic governing bodies have stressed the importance of diagnostic testing as part of the comprehensive strategy to combat COVID-19. As laboratories created and improved COVID-19 testing programs, the AMA, CMS, CDC, and federal payers scrambled to develop applicable coding, reimbursement, and coverage rules and policies. This CodeMap® Webinar will review the existing and developing rules that labs must follow to submit claims, get paid, and remain in compliance. In addition, our experts will explore potential issues that may develop in the coming months and years. This CodeMap® Webinar will address the following:

  • Coding and Medicare Reimbursement: Make sure your laboratory understands all the new codes and reimbursement concerning COVID-19 testing and associated services. Also, you must understand all applicable payment policies created by CMS and its contractors. Finally, our experts will discuss the future of proprietary and temporary HCPCS codes used to report COVID-19 testing. 
     
  • Public Health Emergency (PHE): The DHHS has extended the PHE for COVID-19 four times since January 31, 2020. As long as the PHE is in place, federal agencies are waiving many reporting and oversight requirements. Our experts will discuss when this might end and what it means for clinical laboratories. 
     
  • Future Testing Trends: Even after the PHE ends, the demand for COVID-19 testing will continue. We will examine how this testing may be used to determine vaccine effectiveness, perform public health surveillance, monitor workplace safety, and prevent spread of the virus in conjunction with large events and travel. We will also discuss which types and/or combination of testing will be used including molecular tests, antigen tests, and antibody tests. 
     
  • Compliance Considerations: During the pandemic, enforcement actions involving COVID-19 testing have been limited. Do not expect that to continue much longer. Laboratories must understand how to comply with the rules and requirements concerning high-throughput testing, panels including COVID-19 tests and other respiratory pathogens, medical necessity, and who may order COVID-19 tests. 

 

  • Price: $225.00

 
Price each: $225.00
Add to Cart

Video of Presentation and PDF Handouts.


CodeMap® is a Registered Trademark of Wheaton Partners, LLC.